about
A Closer Look at Schlemm's Canal Cell Physiology: Implications for BiomimeticsDevelopment of the mammalian lymphatic vasculatureNFAT proteins: emerging roles in cancer progression.Two heterozygous mutations in NFATC1 in a patient with Tricuspid Atresia.Vascular endothelial growth factor receptor-2 promotes the development of the lymphatic vasculature.Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1.Tie1 is required for lymphatic valve and collecting vessel development.Tumor lymphangiogenesis as a potential therapeutic target.NFAT as cancer target: mission possible?Lymphatic development.The transcriptional control of lymphatic vascular development.Gene expression profile of lymphatic endothelial cells.Transcriptional regulation of endothelial cell and vascular development.Flow-regulated lymphatic vasculature development and signaling.Tissue-engineered lymphatic graft for the treatment of lymphedema.Why increased nuchal translucency is associated with congenital heart disease: a systematic review on genetic mechanisms.The role of NFATc1 in prostate cancer progression: cyclosporine A and tacrolimus inhibit cell proliferation, migration, and invasion.Drainage developers.Sirolimus inhibits lymphangiogenesis in rat renal allografts, a novel mechanism to prevent chronic kidney allograft injury.
P2860
Q26781500-2F2E1FD6-9767-4AF6-8608-698068E4C973Q26852649-862093C4-AD41-448D-91E6-F26630C881B4Q33837647-1B3F4A7D-4CF3-48A2-9817-24636A7BE4FBQ34505005-44251300-DA53-4932-AF4A-1AC27DDE5629Q34984742-FF678FC6-EA5A-4630-A788-E48D7D04E498Q35176376-5A0A9A4E-E561-4008-BE5A-E7444BC02B94Q35218933-6101EACE-1A4D-40EB-832A-8EA27341F7F2Q35838122-5CE15346-CE16-4ED4-B313-240C6673879AQ36455193-46E521E3-4B2D-426A-8BF6-35F520BD8D9CQ37371437-E2D62E73-99E8-46F3-8960-7C58C726A5ADQ37888987-6F462517-FE97-43BC-B91A-F19B6F3C32ACQ37954393-B42CBD54-E235-4516-9DBA-508F52206BBCQ38105531-01342713-B104-4E20-B298-2A1ED9BD406FQ38233041-4E5A9014-65CC-48B9-88E6-5339D8F8B57FQ38253566-2AE0EE83-D1DF-43A2-8203-B00CACE138FFQ38366535-33375988-86A9-48DA-9D99-9466C3343AFCQ38915508-29BC7B1E-7EDE-4AF3-8A49-299188B5E64FQ45760753-B518DB79-DDE2-42F8-8D9F-B94692BE3BE8Q45883054-2F715EB4-976A-4F1E-B4F6-C0BCC64B3DC9
P2860
description
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2009
@ast
im Mai 2009 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2009/05/01)
@sk
vědecký článek publikovaný v roce 2009
@cs
wetenschappelijk artikel (gepubliceerd op 2009/05/01)
@nl
наукова стаття, опублікована в травні 2009
@uk
مقالة علمية (نشرت في مايو 2009)
@ar
name
NFATc1 regulates lymphatic endothelial development
@ast
NFATc1 regulates lymphatic endothelial development
@en
NFATc1 regulates lymphatic endothelial development
@nl
type
label
NFATc1 regulates lymphatic endothelial development
@ast
NFATc1 regulates lymphatic endothelial development
@en
NFATc1 regulates lymphatic endothelial development
@nl
prefLabel
NFATc1 regulates lymphatic endothelial development
@ast
NFATc1 regulates lymphatic endothelial development
@en
NFATc1 regulates lymphatic endothelial development
@nl
P2093
P2860
P921
P1476
NFATc1 regulates lymphatic endothelial development
@en
P2093
Ann L. Akeson
James M. Greenberg
Rishikesh M. Kulkarni
P2860
P304
P356
10.1016/J.MOD.2009.02.003
P577
2009-05-01T00:00:00Z